160 related articles for article (PubMed ID: 30936351)
1. Ocular infiltration as initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with
Tedjaseputra A; Vilcassim FS; Grigoriadis G
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936351
[TBL] [Abstract][Full Text] [Related]
2. Leukemia cutis in a patient with chronic myelomonocytic leukemia.
Claßen A; Kitz J; Perske C; Overbeck T; Bertsch HP; Schön MP; Lippert U
J Dtsch Dermatol Ges; 2018 Jan; 16(1):81-83. PubMed ID: 29288601
[No Abstract] [Full Text] [Related]
3. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey.
Beguin Y; Selleslag D; Meers S; Graux C; Bries G; Deeren D; Vrelust I; Ravoet C; Theunissen K; Voelter V; Potier H; Trullemans F; Noens L; Mineur P
Acta Clin Belg; 2015 Feb; 70(1):34-43. PubMed ID: 25444072
[TBL] [Abstract][Full Text] [Related]
5. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous infiltratiton by chronic myelononocytic leukemia: presentation of three cases].
Prada Garcia C; Sanchez Sambucety P; Rodriguez Prieto MÁ
Dermatol Online J; 2013 Nov; 19(11):20408. PubMed ID: 24314783
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of azacitidine in chronic myelomonocytic leukemia harboring del(20q) - a case report].
Manabe M; Okita J; Takakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
Gan To Kagaku Ryoho; 2014 Jun; 41(6):781-4. PubMed ID: 25129095
[TBL] [Abstract][Full Text] [Related]
9. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
[TBL] [Abstract][Full Text] [Related]
10. Leukemia cutis in a patient with acute monocytic leukemia presenting as unique facial erythema.
Hattori T; Amano H; Nagai Y; Ishikawa O
J Dermatol; 2008 Oct; 35(10):671-4. PubMed ID: 19017048
[TBL] [Abstract][Full Text] [Related]
11. Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.
Menter T; Schlageter M; Bastian L; Haberthür R; Rätz Bravo AE; Tzankov A
Hematol Oncol; 2014 Mar; 32(1):47-51. PubMed ID: 23625339
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML).
Gorczyca W
Methods Cell Biol; 2004; 75():665-77. PubMed ID: 15603447
[No Abstract] [Full Text] [Related]
13. Generalized granuloma annulare as an initial manifestation of chronic myelomonocytic leukemia: a report of 2 cases.
Hinckley MR; Walsh SN; Molnár I; Sheehan DJ; Sangueza OP; Yosipovitch G
Am J Dermatopathol; 2008 Jun; 30(3):274-7. PubMed ID: 18496432
[TBL] [Abstract][Full Text] [Related]
14. Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13, +15 double trisomy resulting in an adverse outcome.
McGrattan P; Humphreys M; Hull D; McMullin MF
Ulster Med J; 2007 Sep; 76(3):131-5. PubMed ID: 17853637
[TBL] [Abstract][Full Text] [Related]
15. Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patients.
Haferlach T; Schoch C; Schnittger S; Kern W; Löffler H; Hiddemann W
Br J Haematol; 2002 Aug; 118(2):426-31. PubMed ID: 12139726
[TBL] [Abstract][Full Text] [Related]
16. Obstructive uropathy associated with myelomonocytic infiltration of the prostate.
Hope-Gill B; Goepel JR; Collin RC
J Clin Pathol; 1998 Apr; 51(4):340-2. PubMed ID: 9659253
[TBL] [Abstract][Full Text] [Related]
17. Acute liver failure due to liver parenchymal infiltration with acute myelogenous leukaemia in a patient with myelodysplastic syndrome.
Sobotka LA; Malli A; Chen W; Mumtaz K
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954762
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review.
Thorpe M; Montalvão A; Pierdomenico F; Moita F; Almeida A
Leuk Res; 2012 Aug; 36(8):1071-3. PubMed ID: 22607959
[TBL] [Abstract][Full Text] [Related]
19. A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia.
Drummond MW; Pocock C; Boissinot M; Mills J; Brown J; Cauchy P; Cross NC; Hartley S; Kell J; Szubert A; Cockerill PN; Bowen DT
Leukemia; 2014 Jul; 28(7):1570-2. PubMed ID: 24569776
[No Abstract] [Full Text] [Related]
20. Chronic myelomonocytic leukemia revealed by uncontrollable hematuria.
Bane AL; Enright H; Sweeney EC
Arch Pathol Lab Med; 2001 May; 125(5):657-9. PubMed ID: 11300938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
